Though J&J is one of the country's largest drugmakers, the lawsuit argues, it failed to use its buying power when purchasing medications to negotiate the best prices for medicines for workers on its health plan.
FTX's bankruptcy in November left customers and investors facing billions of dollars of potential losses, and several of the company's executives have been charged with various types of financial fraud.
CFO and CEO of London-based Rio Tinto are charged with falsely inflating asset valuations; SEC seeks civil penalties and to bar the men from serving on corporate boards.